An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters
Abstract The SARS-CoV-2 Omicron BA.2.86 variant and its descendant lineages, including JN.1, are rapidly spreading and becoming dominant globally. Vaccination is an essential primary preventative measure. While mRNA vaccines have been widely used worldwide, it is essential that we continue to prepar...
Saved in:
Main Authors: | Ryuta Uraki, Mutsumi Ito, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Masafumi Endo, Seiya Yamayoshi, Yoshihiro Kawaoka |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Viruses |
Online Access: | https://doi.org/10.1038/s44298-025-00096-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
by: Jingyun Yang, et al.
Published: (2025-01-01) -
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01) -
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformResearch in context
by: Jennifer L. Nguyen, et al.
Published: (2025-01-01) -
Neutralizing antibody responses to three XBB protein vaccines in older adults
by: Guo-Jian Yang, et al.
Published: (2025-02-01) -
Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01)